Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haden T Bunn

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|July 10, 2023
Bayesian model-guided antimicrobial therapy in pediatricsHaden T Bunn, Jogarao V S Gobburu, Lindsey M Floryance
Journal of Acquired Immune Deficiency Syndromes (1999)|November 13, 2023
Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/RifapentineKristina M Brooks, Alice K Pau, Doris Swaim, et al.
Journal of Clinical Pharmacology|June 25, 2020
The Effect of GS-548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS-6637 in Healthy AdultsHaden T Bunn, Elana Rosenthal, Poonam Mathur, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|July 10, 2023
Bayesian model-guided antimicrobial therapy in pediatricsHaden T Bunn, Jogarao V S Gobburu, Lindsey M Floryance
Journal of Acquired Immune Deficiency Syndromes (1999)|November 13, 2023
Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/RifapentineKristina M Brooks, Alice K Pau, Doris Swaim, et al.
Journal of Clinical Pharmacology|June 25, 2020
The Effect of GS-548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS-6637 in Healthy AdultsHaden T Bunn, Elana Rosenthal, Poonam Mathur, et al.
Pageof 1